close

Clinical Trials

1 2 3 4 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2019-11-19 TX200 kidney transplantation 1-2 Sangamo Therapeutics (USA - CA) Transplantation
2019-07-29 genome editing using zinc finger nucleases (ZFNs) preclinical Sangamo Therapeutics (USA - CA)
2019-07-01 allele-selective zinc finger protein transcription-factors (ZFP-TFs) Huntington's disease preclinical Sangamo Therapeutics (USA - CA) Rare diseases - Neurodegenerative diseases
2019-03-28 VY-AADC Parkinson's disease 1b Voyager Therapeutics (USA-MA) Neurological diseases - Neurodegenerative diseases
2019-03-19 zinc finger protein transcription factors (ZFP-TFs) Tau pathology, tauopathies preclinical Sangamo Therapeutics (USA - CA) Neurodegenerative diseases
2019-03-08 zinc finger nuclease (ZFN) platform technology preclinical Sangamo Therapeutics (USA - CA)
2019-02-20 ST-920 Fabry disease 1-2 Sangamo Therapeutics (USA - CA) Rare diseases - Genetic diseases
2019-01-07 dry Age-Related Macular Degeneration (AMD) registry Gemini Therapeutics (USA) Ophthalmological diseases
2019-01-07 VY-AADC Parkinson's disease 2 Voyager Therapeutics (USA-MA) Neurological diseases - Neurodegenerative diseases
2018-12-17 SB-FIX - adeno-associated virus serotype 2/6 (rAAV2/6) vectors encoding zinc finger nucleases (ZFNs) and human factor 9 gene (SB-FIX) hemophilia B 1-2 Sangamo Therapeutics (USA - CA) Rare diseases - Genetic diseases - Hematological diseases
2018-10-19 apceth-201 acute graft-versus-host disease (aGvHD) preclinical apceth (Germany) Transplantation
2018-10-16 BI-1607 (anti FcgammaRllB antibody/anti-PD1 antibody) solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-16 anti FcgammaRllB antibody/anti-PD1 antibody program solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-16 BI-1808 solid tumors preclinical BioInvent (Sweden) Cancer - Oncology
2018-10-15 BPS-804 (setrusumab) osteogenesis imperfecta (OI) 2b Mereo Biopharma (UK) Bone diseases - Metabolic diseases - Rare diseases
2018-10-15 KB103 (replication defective herpes simplex type 1 virus (HSV-1) vector expressing human COL7 protein) dystrophic epidermolysis bullosa 1-2 Krystal Biotech (USA - PA) Rare diseases - Genetic diseases - Dermatological diseases
2018-10-15 ARO-ANG3 dyslipidemia 1 Arrowhead Pharmaceuticals (USA - CA) Metabolic diseases
2018-10-12 zanubrutinib - BGB-3111 chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstöm's macroglobulinemia 1 BeiGene (China) Cancer - Oncology
2018-10-12 evobrutinib - M2951 relapsing multiple sclerosis (RMS) 2 Merck KGaA (Germany) Autoimmune diseases - Neurodegenerative diseases
2018-10-12 Opdivo® (nivolumab) relapsed small cell lung cancer 3 BMS (USA - NY) Cancer - Oncology